Professional Documents
Culture Documents
General Health
https://www.optibacprobiotics.com/uk/professionals/
latest-research/general-health/probiotics-for-diabetes
Growing research continues to demonstrate that the gut microbiome plays a pivotal role
in type 2 diabetes. Probiotics can help to modulate the immune system by correcting
underlying inflammation which can accelerate diabetes and lead to long-term health
complications. Improving metabolic function and the overall state of the gut
microbiome encourages the diversity and growth of beneficial bacterial species which
have been shown to lower fasting blood sugar. To find out more about the role our gut
microbiota play in our metabolic health, please see: Do gut microbes hold the key to
better metabolic health?
What is diabetes?
Are probiotics good for diabetics?
Should you be taking probiotics for diabetes?
Can analysing the gut microbiota predict diabetes risk?
Which probiotic is best for diabetes?
Key takeaways
What is diabetes?
Diabetes is a disease whereby the body's ability to regulate blood glucose is
compromised. It is one of the fastest-growing diseases in the UK and it’s estimated that
by 2025, 5 million people will have diabetes in the UK1.
There are di erent types of prebiotics, for example, Fructooligosaccharides (FOS) which
are non-digestible, so do not influence blood sugar levels and therefore would not need
to be considered by diabetics.
Please read the following article to learn more about the clinical trials that have been
conducted linking probiotics to better health outcomes: Probiotics: do they work, and
where’s the evidence?
It is thought that metabolic disease may occur through a mechanism that is linked to
increased gut permeability, which can cause systemic low-grade inflammation.
Probiotics can help support many of the mechanisms linked to intestinal permeability,
which is thought to drive metabolic disease. For more information, please see: Could
probiotics help with leaky gut?
Another way in which probiotics are known to help with metabolic health is that they
increase the secretion of an intestinal hormone called glucagon-like peptide 1 (GLP-1)2,
which is critical for stimulating insulin secretion, and enables the proliferation and
regeneration of pancreatic beta cells that synthesise, store and release insulin.
A study from 2015, found that a er just 90 days of probiotic consumption, diabetic rats
were able to reduce their blood glucose levels in a similar way to the healthy rats3
(meaning that they were better able to produce insulin). Interestingly the blood glucose
levels in the healthy rats remained unchanged because those rats were already
managing their glucose and didn’t need more insulin.
It is well documented that those with type 2 diabetes have an entirely di erent
composition of gut microbiota than healthy people5. This over the years has led
researchers to develop a new model for early diagnosis, with better predictive value
than the model used currently, which uses body-mass index and waist-hip ratio.
This study suggests that by examining the patient’s gut microbiota, we can predict
which patients are at risk of developing diabetes. The question is – does the
composition of the gut microbiota promote the onset of age-related diabetes? If this is
the case, this would indicate new opportunities to prevent disease.
Further studies have been conducted to support this theory, suggesting that the
composition of intestinal bacteria changes over time in a negative way in those people
who are pre-diabetic and this could therefore possibly be a predictor of diabetes6. In
this particular study, researchers found that the men whose blood sugar control was
stable during the study had more gut bacteria that are considered beneficial for
metabolic health. On the other hand, those who were pre-diabetic didn’t have such a
healthy microbiota, or with fewer healthy bacteria and more harmful bacteria6 (o en
referred to as dysbiosis) which is an imbalance of gut bacteria. Furthermore, the men
who had improved glucose control over the course of the study were found to have
higher levels of Akkermansia, which is again associated with better metabolic health.
What these studies show us is that although there has been previous research linking
the balance of our gut bacteria with type 2 diabetes, this is the first piece of research to
suggest that the alteration in the composition of our gut bacteria can be seen in the
early stages of diabetes, or pre-diabetes. Going forward future studies need to be
conducted to determine if it is the changes in gut bacteria that can a ect the
development of type 2 diabetes. Otherwise, we will not know If the changes simply
reflect that the person is su ering from type 2 diabetes.
Changes in gut bacteria are thought to a ect the development of type 2 diabetes
Several probiotic strains have been shown to possess antidiabetic e ects, such as those
in Lactobacillus and Bifidobacterium genus because they improve biomarkers of
inflammation and oxidative stress and lower fasting blood glucose by promoting an
anti-inflammatory gut microbiota, which we know is linked to better metabolic health. 9,
10, 11.
Interestingly prebiotics have also been shown to support those with diabetes. In one
study participants who had recently been diagnosed with type 1 diabetes were given
high amylose starch which was shown to alter the gut microbiome profile, increasing
the production of health-promoting compounds called short-chain fatty acids (SCFA).
This resulted in improved glycemia, insulin sensitivity, and secretion.12 This increase in
gut bacterial diversity demonstrated improved glycemia just a er four weeks of
prebiotic consumption. For more information on this, please read: Uses of prebiotics.
Key takeaways
We have covered a lot in this article, so here is a summary of the main points:
It is well documented that those with type 2 diabetes have an entirely di erent
composition of gut microbiota than healthy people.
Examining the gut microbiota, could predict an individual’s risk of developing
diabetes.
Several probiotics have been shown to possess antidiabetic e ects.
Prebiotics have also been found to positively a ect metabolic health by improving
insulin sensitivity.
For further related reading, you might be interested in one of the following articles:
References
1. https://www.diabetes.org.uk/Documents/About%20Us/Statistics/Diabetes-key-stats-guidelines-
April2014.pdf
2. Ya Li. (2022). The e ects of probiotic administration on patients with prediabetes: a meta-analysis and
systematic review.
3. Duan FF, Liu JH, March JC.(2015) Engineered Commensal Bacteria Reprogram Intestinal Cells Into
Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes. Diabetes. Published online
January 27
5. Bäckhead, F. et al (2013) Gut metagenome in European women with normal, impaired and diabetic
glucose control. Nature.
6. Ciubotaru I, et al “Significant Di erences in fecal microbiotia are associated with various stages of
glucose tolerance in African-American male veterans” ENDO 2015; abstract FRI-597
7. Qin, J. et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature,
publish online ahead of print.
8. Hao Wu (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2
diabetes, contributing to the therapeutic.
10. Kaveh Naseri. (2018). Probiotics and synbiotics supplementation improve glycemic control
parameters in subjects with prediabetes and type 2 di. National Library of Medicine.
11. Hui Juan Zheng a (2019) The e ect of probiotic and synbiotic supplementation on biomarkers of
inflammation and oxidative stress in diabetic pat. Pharmacological Research. 142(0), pp.303-313.
12. Heba Ismail. (2022). LBSUN309 The E ect Of Prebiotics In Newly Diagnosed Youth With Type 1
Diabetes (T1D). National Library of Medicine.
The Probiotic Professionals site is run by the nutrition team at Contact us Privacy policy
Optibac Probiotics. This site includes new research and news
Home Cookie policy
related to probiotics. The material on this website is intended to
be educational, informative, and non-commercial. Content is not PROBIOTICS DATABASE Terms & conditions
limited to coverage of strains in the Optibac range.
Professional Knowledge
For further reading you can also visit the Probiotics Learning Lab,
FAQs
which is open to members of the public and can be signposted to
clients seeking more information.